NeuroBo Pharmaceuticals, Inc. (NRBO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.88B |
| Enterprise Value | 2.87B |
| P/E Ratio | -0.26 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.84 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.91 |
| Return On Equity | -1.73 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 19,000 |
| Net Income | -12.97M |
| Diluted EPS | -7.35 |
| Total Cash | 13.73M |
| Total Cash/Share | 2.83 |
| Total Debt | 194,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.73 |
| Book Value Per Share | 1.87 |
| 52-Week Change | -28.48 |
| 52-Week High | 2.36 |
| 52-Week Low | 2.36 |
| Moving Average 50 Days | 0 |
| Moving Average 200 Days | 0 |
| Average Volume | 0 |
| Shares Outstanding | 8.62M |
| % Held by Institutions | 4.59 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | December 21, 2023 |